HCG Launches Biograph M CT-World's First Molecular CT ; A Boon For Early Diagnosis

HCG launched the world's 1st Biograph m CT, an advanced technology of a High Definition PET CT scan which is the next level of integrated imaging.

Bangalore: Advancements in medical technology are empowering Clinicians and Doctors across the world to meet challenges faster and better. However to optimize the outcome, know-how is important.

HCG launched the world's 1st Biograph m CT, an advanced technology of a High Definition PET CT scan which is the next level of integrated imaging.

Speaking to the media on this occasion, Dr.Rodney Hicks Professor & Director -Molecular Imaging at Peter Mac Callum Cancer Center, Melbourne, Australia said "This is an advanced technology with the ability to make the diagnosis precise. Thus during treatment, radiotherapy can be targeted to the cancer cells without affecting the good cells. With this technology the side effects of radiotherapy can be minimized".

Dr. Ajaikumar Chairman HCG said "Metabolic changes of an organ can be noticed much before anyone can see anatomical changes. Thus early diagnosis is possible through PET CT.India has already acquired 70 PET CT scan machines, of which HCG alone has four similar machines across its centers and has ordered five more PET CT scanners. However HCG is the only center in India to have acquired HD PET CT.

Adding to this Dr.K G Kallur', Director - Molecular Imaging HCG said that the patient can undergo an HD PET CT after a few weeks of treatment to see if the drugs are having a positive effect. Since Cancer treatment is expensive if the drugs don't have a positive effect on the patient, the drugs can be changed immediately. This way the patient and his family no longer have to shell out money for a futile treatment, he added.
As a knowledge sharing initiative HCG and Siemens organized an exclusive preview of Biograph m CT for over 400 doctors from India.

About HCG:

HealthCare Global Enterprises Ltd. (HCG), South Asia's largest cancer care network, currently owns and manages a network of 20 state-of-the-art cancer treatment centers across South Asia. HCG focuses on the entire value chain in cancer care from diagnostics, high end imaging services, organ preservation surgeries, to cutting edge research. It has a vision to provide high quality, affordable and comprehensive cancer care to all segments of the society. Bangalore Institute of Oncology (BIO), the flagship of HCG, was set up almost two decades ago by Dr. Ajaikumar who had then just moved back from the US and was the first dedicated comprehensive Cancer Centre in the private space.

For more details log on to www.hcgoncology.com